Ovarian cancer is a lifetime risk of 40%–60% for women who carry hereditary BRCA1 (Breast Cancer gene 1) and BRCA2 (Breast Cancer gene 2) mutations. This evidence concerns the gene BRCA2 and ovarian carcinoma.